Combined statistical decision limits based on two GH-2000 scores for the detection of growth hormone misuse. (August 2022)

• Record Type: Journal Article
• Authors: Liu, Wei; Bretz, Frank; Böhning, Dankmar; Holt, Richard I.G.; Han, Yang; Böhning, Walailuck; Guha, Nishan; Cowan, David A.
• Is Part Of: Statistical methods in medical research. Volume 31:Number 8(2022)
• Page Start: 1439
• Page End: 1448
• Publication Date: 2022-08
• Subjects: Bayesian tolerance regions -- growth hormone misuse detection -- growth hormone-2000 scores -- decision limits -- tolerance limits -- tolerance regions; Medicine -- Research -- Statistical methods -- Periodicals; Research -- Periodicals; Review Literature -- Periodicals; Statistics -- methods -- Periodicals; Médecine -- Recherche -- Méthodes statistiques -- Périodiques; 610.727
• DOI: 10.1177/09622802221093730
• Languages: English
• ISSNs: 0962-2802

Abstract

The growth hormone-2000 biomarker method, based on the measurements of insulin-like growth factor-I and the amino-terminal pro-peptide of type III collagen, has been developed as a powerful technique for the detection of growth hormone misuse by athletes. Insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen are combined in gender-specific formulas to create the growth hormone-2000 score, which is used to determine whether growth hormone has been administered. To comply with World Anti-Doping Agency regulations, each analyte must be measured by two methods. Insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen can be measured by a number of approved methods, each leading to its own growth hormone-2000 score. Single decision limits for each growth hormone-2000 score have been introduced and developed by Bassett, Erotokritou-Mulligan, Holt, Böhning and their co-authors in a series of papers. These have been incorporated into the guidelines of the World Anti-Doping Agency. A joint decision limit was constructed based on the sample correlation between the two growth hormone-2000 scores generated from an available sample to increase the sensitivity of the biomarker method. This paper takes this idea further into a fully developed statistical approach. It constructs combined decision limits when two growth hormone-2000 scores from different assay combinations are used to decide whether an athlete has been misusing growth hormone. The combined decision limits are directly related to tolerance regions and constructed using a Bayesian approach. It is also shown to have highly satisfactory frequentist properties. The new approach meets the required false-positive rate with a pre-specified level of certainty.